# Edwards Lifesciences Corporation (EW) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $1.26B |
| 2024 | $1.38B |
| 2023 | $1.31B |
| 2022 | $1.50B |
| 2021 | $1.69B |
| 2020 | $898M |
| 2019 | $1.15B |
| 2018 | $748M |
| 2017 | $1.09B |
| 2016 | $751M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $478M |
| 2025-09-30 | $307M |
| 2025-06-30 | $411M |
| 2025-03-31 | $395M |
| 2024-09-30 | $351M |
| 2024-06-30 | $367M |
| 2024-03-31 | $349M |
| 2023-09-30 | $366M |
| 2023-06-30 | $264M |
| 2023-03-31 | $388M |
| 2022-09-30 | $402M |
| 2022-06-30 | $460M |
| 2022-03-31 | $439M |
| 2021-09-30 | $390M |
| 2021-06-30 | $542M |
| 2021-03-31 | $384M |
| 2020-09-30 | $358M |
| 2020-06-30 | -$170M |
| 2020-03-31 | $358M |
| 2019-09-30 | $294M |
| 2019-06-30 | $268M |
| 2019-03-31 | $274M |
| 2018-09-30 | $249M |
| 2018-06-30 | $252M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/EW/operating-income)